Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000632832 | SCV000754028 | pathogenic | Peutz-Jeghers syndrome | 2017-09-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in STK11 are known to be pathogenic (PMID: 15188174, 16287113). This variant has been reported in individuals affected with Peutz–Jeghers syndrome (PMID: 9887330, 26979979). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Arg86*) in the STK11 gene. It is expected to result in an absent or disrupted protein product. |
Baylor Genetics | RCV003459509 | SCV004205605 | pathogenic | Melanoma, cutaneous malignant, susceptibility to, 1 | 2022-08-10 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000632832 | SCV004933525 | pathogenic | Peutz-Jeghers syndrome | 2024-02-09 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. |